A Novel DNA Vaccine Design Improves Chances of Inducing Anti-Tumor Immunity
Friday, February 24, 2017 - 11:31
in Health & Medicine
Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc. have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important cancer antigen targets.